Status:
COMPLETED
Oxytocin Effect on Attention Inhibition
Lead Sponsor:
University of Electronic Science and Technology of China
Conditions:
Healthy
Eligibility:
MALE
18-30 years
Phase:
NA
Brief Summary
Effects of intranasal oxytocin (24IU) on cognitive control of attention
Detailed Description
The cognitive control of attention towards neutral and emotional stimuli represents a key functional domain and disruptions in this domain have been associated with a range of psychiatric disorders. S...
Eligibility Criteria
Inclusion
- Male, healthy participants
- Non smokers
Exclusion
- Previous or current medical, psychiatric, neurological disorder
- Regular medication
- Use of any psychoactive substances in the 24 hours before experiment
- Contra-indications for oxytocin
- Contra-indications for eye-tracking data acquisition
Key Trial Info
Start Date :
December 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2018
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT03486925
Start Date
December 19 2017
End Date
August 28 2018
Last Update
March 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China, 611731